Pancreaticobiliary disease
Conditions
Interventions
Control group (The pancreatic stent was placed after all the bile duct operations complete):Pancreatic duct stent
Intervention group :Pancreatic duct stent (pancreatic duct stent was placed when guide wire entered the pancreatic duct)
Sponsors
Renmin hospital of Wuhan University
Eligibility
Sex/Gender
All
Age
18 Years to 89 Years
Inclusion criteria
Inclusion criteria: Patients aged 18-89 years with native papilla and bile duct as the target duct were eligible for inclusion. Laboratory tests, including routine blood tests, liver function tests,and serum and urine amylase were required to be evaluated for eligibility.
Exclusion criteria
Exclusion criteria: 1. Patients with a low risk of pancreatitis who did not need to place pancreatic duct stents; 2. The patient with acute pancreatitis; 3. Abnormal biliopancreatic confluence; 4. After Roux-EN-Y or Billroth-II gastrointestinal reconstruction surgery; 5. History of chronic pancreatitis; 6. Patients with contraindications of ERCP; 7. Patients with non-native papilla; 8. Pregnant women are also excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percent of PEP; | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of cannulation success;Total time of the procedure;Amylase; | — |
Countries
China
Contacts
Public ContactZhongyin Zhou
Renmin hospital of Wuhan University
Outcome results
None listed